Talk to Robyn

(866) 682 9815

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics, March 2013 (p4)

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

91-120 of about 2 600 reports
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biotechnology
Beijing Genomics Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Beijing Genomics Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Response Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Response Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Human Genome Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Human Genome Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
KINAXO Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

KINAXO Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biotechnology
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
  • Countries : United States
Applied Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Applied Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
Baotou Dongbao Biotech Co. Ltd. (300239) - Financial and Strategic SWOT Analysis Review

Baotou Dongbao Biotech Co. Ltd. (300239) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary This comprehensive SWOT profile of Baotou Dongbao Biotech Co. Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Cell Biotech Co., Ltd. (Symbol:049960) SWOT Analysis, Strategy, Revenues and Profits

Cell Biotech Co., Ltd. (Symbol:049960) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Bruker Corporation (Symbol:BRKR) SWOT Analysis, Strategy, Revenues and Profits

Bruker Corporation (Symbol:BRKR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biocompatibles International Ltd. - Strategic SWOT Analysis Review

Biocompatibles International Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used for the treatment of cancer and benign tumors. The company is divided ...

  • Industries : Biological Therapy
  • Countries : United States, United Kingdom
AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary AdvanSource Biomaterials Corporation (AdvanSource) is a biomaterial manufacturer, based in the US. The company develops polymer based materials for the medical and pharmaceutical industries. Its ...

  • Industries : Biomaterial
  • Countries : United States
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Chemcel Biotech Limited (Symbol:533026) SWOT Analysis, Strategy, Revenues and Profits

Chemcel Biotech Limited (Symbol:533026) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Anhui Bbca Biochemical Co., Ltd. (Symbol:000930) SWOT Analysis, Strategy, Revenues and Profits

Anhui Bbca Biochemical Co., Ltd. (Symbol:000930) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
BioTech Capital Limited (Symbol:BTC) SWOT Analysis, Strategy, Revenues and Profits

BioTech Capital Limited (Symbol:BTC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
CellCyte Genetics Corporation (Symbol:CCYG) SWOT Analysis, Strategy, Revenues and Profits

CellCyte Genetics Corporation (Symbol:CCYG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary This comprehensive SWOT profile of CCM Duopharma Biotech Bhd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Cheil Bio Co., Ltd. (Symbol:052670) SWOT Analysis, Strategy, Revenues and Profits

Cheil Bio Co., Ltd. (Symbol:052670) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : South Korea
Changmao Biochemical Engineering Co., Ltd. - Financial and Strategic SWOT Analysis Review

Changmao Biochemical Engineering Co., Ltd. - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary This comprehensive SWOT profile of Changmao Biochemical Engineering Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
Abl Biotechnologies Limited (Symbol:526955) SWOT Analysis, Strategy, Revenues and Profits

Abl Biotechnologies Limited (Symbol:526955) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
Anhui Anke Biotechnology (Group) Co., Ltd. (300009) - Financial and Strategic SWOT Analysis Review

Anhui Anke Biotechnology (Group) Co., Ltd. (300009) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2013
  • by Global Data

Summary This comprehensive SWOT profile of Anhui Anke Biotechnology (Group) Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology

» Download Public Reports

About 9 000 reports
Intercell AG - Company Report for Year 2013

Intercell AG - Company Report for Year 2013

  • Company report
  • May 2013
  • 4 pages

... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...


» Read our Company Profiles

99 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.